Life Insurance News Roundup: Early October 2026 — A $21 Billion Disclosure Lawsuit, Bitcoin Whole Life Insurance, and Two Carriers Rewriting Term Rates
The first full week of October 2026 has produced one of the more consequential news clusters of the year for life insurance consumers: a fresh federal lawsuit accusing two carriers tied to Guggenheim Partners of hiding $21 billion in related-party investments, Australia’s first-of-its-kind genetic-testing ban taking effect on October 8, the biggest term-rate repricing windows of the fall at Banner Life and North American Company, a $37.5 million funding round for a Bitcoin-denominated life insurer, and first-year-premium growth in India that is reshaping what insurers worldwide say at regulatory hearings. Below, we’ve rewritten each story from primary filings, press releases, and exchange filings with original analysis about what it means for an American policyholder. Not one of these is a “bond 007 becomes unaffordable” scare story — every single one carries a specific action item you can act on.
The Big Story: A $21 Billion Related-Party Disclosure Lawsuit Against Delaware Life and Clear Spring
A suit filed this week in federal court accuses two life insurers controlled by Los Angeles Dodgers CEO Mark Walter — Delaware Life Insurance Company and Clear Spring Life and Annuity Company — of concealing roughly $21 billion in loans to affiliated companies and of failing to tell elderly annuity investors that the insurers were under federal investigation. Plaintiffs Robert Kalinsky and Ira Rosner, both seniors on fixed annuity income, are represented by Stuart Davidson of Robbins Geller Rudman & Dowd. Both carriers are part of Group 1001, the insurance platform under TWG Global Holdings; Walter is CEO of Guggenheim Partners and co-chairman of TWG Global. The complaint also names Guggenheim Partners itself. (Source: American Banker; the class action is not yet widely syndicated to trade press, which is why you may not have seen it on industry wire services.)
The heart of the allegation is not that the investments themselves were illegal — private-credit loans to affiliated asset managers are a well-established feature of modern life-insurer portfolios. The heart is the disclosure: Delaware Life and Clear Spring repeatedly told policyholders, rating agencies, and state regulators that only 3% to 4% of invested assets were in related-party transactions. Internal reviews and financial restatements later showed the real figures were 42% at Delaware Life ($18.3 billion) and 59% at Clear Spring ($5.9 billion) as of late 2025 — the Clear Spring figure was, per the complaint, five times the insurer’s total capital and policyholders’ surplus. By June 30, 2026, Delaware had pulled back to 39% and Clear Spring to 49%, while the combined restatement equaled $21 billion.
Restatement Snapshot: The Two Carriers Side by Side
| Dimension | Delaware Life | Clear Spring Life & Annuity |
|---|---|---|
| Originally disclosed related-party share of assets | 3–4% | 3–4% |
| Restated share at year-end 2025 | 42% ($18.3B) | 59% ($5.9B) |
| Restated share at June 30, 2026 | 39% | 49% |
| Combined restated related-party loans | $21 billion | |
| Federal grand-jury subpoenas | February 2026, both carriers | |
The practical reading: after a whistleblower raised the alarm and federal grand-jury subpoenas landed in February, both carriers reportedly reclassified those exposures in their filings. The complaint frames the misreporting in blunt terms — annual statements that named wrong affiliate percentages, submitted to state regulators under penalty of law. The broader industry implication is that regulated life carriers are structuring more and more of their portfolios around affiliated loans to their own asset-management arms — exactly the pattern consumer groups have warned about, and exactly why state regulators are now weighing expanded disclosure rules for private-credit investments. When an insurer’s captive assets exceed 40–50% of its book, solvency math narrows and dispersion across carriers widens dramatically.
What Annuity Buyers Should Ask
- Does your carrier sit inside an asset-manager holding structure (Guggenheim, Apollo, KKR, Blackstone, A-Cap, Golden Gate Capital) whose core business is private credit?
- Did your annuity’s most recent AM Best rating run confirm “stable” or was it revised / placed “under review”? A carrier that has been downgraded within the last 6 months deserves a second look.
- What does your state guarantee association actually cover? Limits are typically $300,000 on the death benefit and $100,000 cash surrender value for policyholders who purchased a policy from a licensed life carrier — so a $500,000 annuity has no guarantee of full recovery if the insurer goes under.
- Get a written statement from your carrier about total, not net, exposure to affiliated entities today.
The takeaway here isn’t “everyone’s unsafe.” It’s that reported “insurer strength” numbers are recalculated behind closed doors, not on the surface of annual statements. When you buy from a carrier whose affiliate structure dominates its portfolio, you’re effectively underwritten twice — once by its own board, and once by an insurance regulator that doesn’t own the loan book. Shop accordingly. (AM Best keeps a searchable rating directory for every carrier at ratings.ambest.com/search.)
Australia’s Genetic-Testing Ban Takes Effect October 8 — and the US Still Has No Equivalent for Life Insurance
From October 8, 2026 (today), Australian life insurers cannot ask for or use the results of a predictive genetic test — yours or a blood relative’s — when they decide whether to offer you cover. A test you or a genetic relative has already taken is off the table entirely — for cover taken out on or after that date, you no longer have to disclose the test result, and staying silent doesn’t count as non-disclosure. The change comes from the Treasury Laws Amendment (Genetic Testing Protections in Life Insurance and Other Measures) Act 2026, which received Royal Assent on April 8, 2026 and amends the Insurance Contracts Act 1984 and the Disability Discrimination Act 1992. (Researchers like Monash University’s Jane Tiller spent years arguing for the reform; research holds that roughly 1 in 50 young Australians carries a high-risk genetic variant — and, before this law, many of them delayed or avoided clinically useful genetic testing because of insurance fear.)
- What’s banned: insurers asking for or using your — or a blood relative’s — genetic-test result in underwriting, whether or not the result actually affected the decision, from October 8.
- What’s still on the table: a disease someone has been clinically diagnosed with. “My mother was diagnosed with breast cancer at 45” remains a fair underwriting question. “My sister tested positive for BRCA1” is a different story — the test predicts risk; the diagnosis is already realized illness.
- Pre-symptom diagnoses: a diagnosis made before symptoms appear (e.g., Lynch syndrome flagged before any cancer) is itself protected, per regulations made September 16, 2026.
- Duty of disclosure: for cover taken out on or after October 8 — and for changes, reinstatement, or extension of existing cover agreed from that date — nondisclosure of protected genetic information cannot itself be treated as a misrepresentation. Existing policies aren’t rewritten.
Why does this matter to an American reader? Because the US federal regime — the Genetic Information Nondiscrimination Act (GINA) — contains an explicit carve-out for life, long-term-care, and disability insurance. GINA bans employer health-insurance discrimination on genetic data but doesn’t touch life-insurance underwriting. California’s AB 1798 (the Safeguarding Genetic Information Act, signed September 30, effective January 1, 2027) removes the $1.5M face-value exception, covers reinsurers and DTC-equivalent vendors, and bars full-genome use — but it’s state-level. Connecticut’s Public Act 26-64 kicked in October 1; Illinois has proposed amendments. In short: Australia just created the “you can be silent” symmetry nationwide; California and Connecticut created pieces of it; the rest of America has neither. Until GINA is amended, an American applicant’s predictive genetic results — including anything from a consumer DNA test — remain fair game in life-insurance underwriting.
We expanded on the DNA-and-data framing in our early-October “The DNA and Data Reckoning” roundup; the fresh angle this week is date-based — Australia’s ban is now enforceable, not just passed. American buyers who have already taken 23andMe or other DTC tests should read our guide to underwriting family history — the Australian rule maps one-for-one onto the American question about what insurers can (and can’t) ask.
October’s Carrier Rate Rewrites: A Reader’s Field Guide to the Banner and North American Application Windows
Every fall, carriers quietly reprice their term products, and every fall consumers get burned by three separate implementation rules. This month two major carriers have active or recent windows that illustrate exactly how application mechanics differ from product mechanics: Banner Life (OPTerm) and North American Company (ADDvantage Term), both using their own application-date rules. If you or an agent started an application in late September, your rate depends on which rule your application followed — and a drop ticket alone no longer guarantees the pre-change price.
What Each Window Actually Did
Banner Life: A September 22, 2026 rate change to OPTerm level-premium pricing across seven term lengths (10, 15, 20, 25, 30, 35, 40 years), all underwriting classes and coverage bands. The carrier will apply the more favorable of the pre- or post-change rate to (a) applications already in flight and (b) new applications received at the home office by October 22, 2026. For digital submissions (AppAssist / direct-access), the COUNT of the “received” moment is when the formal application arrives — a drop ticket alone doesn’t preserve the price. Applications received October 23 or later use the new rates. Also watch: William Penn, Banner’s New York issuing affiliate, follows a separate May 7, 2026 rate change, so New York applications are governed by a different rulebook.
North American Company: An ADDvantage Term rate change effective September 28, 2026. For an electronic application to keep the pre-change schedule, it needed to be locked, signed, and submitted by September 27 — locking without signing didn’t count. Paper applications follow a signature-date rule instead: the signature date determines which rate schedule applies, and North American says applications should be received within seven calendar days of signature. North American’s illustration systems updated on September 28.
Deadline Comparison: The Fine Print That Costs Money
| Carrier | Rate-change date | Application freeze / cutoff | What was in flight | Paper vs. digital difference |
|---|---|---|---|---|
| Banner Life (OPTerm) | Sept 22, 2026 | Oct 22, 2026 (home-office receipt) | Best-of-old-or-new treatment for 10/15/20/25/30/35/40-year terms | Digital: drop ticket insufficient — formal application must arrive by Oct 22. Paper apps unchanged. |
| North American (ADDvantage Term) | Sept 28, 2026 | Locked + signed + submitted by Sept 27, 2026 | Rate schedule applies by application “lock” + signature + submission | Digital: lock ≠ rate lock. Paper: signature date controls; must be received within 7 calendar days. |
Two practical lessons carry beyond these carriers. First, term pricing is a snapshot, not a promise: you have to compare the same policy at the same coverage tier on the same day to see what’s actually cheaper. Second, “locking in the rate” is a legal claim that depends on which step you last completed — one reason our term life rates by age guide emphasizes reading the application’s lock/sign/submit language before treating any quote as final. If you have a Banner OPTerm application in flight right now, the October 22 deadline is the only one between you and the new rates; miss it and a three-week time-of-application difference can cost 5–15% on a 20-year term premium.
Meanwhile Raises $37.5 Million as Bitcoin-Denominated Whole Life Grows Outside the US
Meanwhile, the Bermuda-based insurer licensed to operate entirely in bitcoin, raised $37.5 million in fresh funding on October 8 from existing investors led by Bain Capital Crypto, alongside Haun Ventures, Framework Ventures, Pantera Capital, Apollo, Northwestern Mutual Future Ventures, and Morgan Creek Digital — bringing total funding above $180 million, with Sam Altman among its backers. The company launched BTC Life 1-Pay, a single-premium whole-life policy built for high-net-worth clients outside the United States, as its second product line after BTC 10-Pay (which is structured for US taxpayers). Since launch, Meanwhile has signed 15 brokers serving wealthy families in Singapore, Hong Kong, the UAE, and Switzerland — including Lioner and Apeiron Group — and reports that net long-term underwriting income is on track to more than double in 2026 versus last year. (Source: Business Wire, October 8, 2026.)
What’s analytically interesting is the customer driver: the press release frames the surge as demand for “a policy denominated in a neutral, non-government asset” amid macro instability in Asia, Europe, and the Middle East. Traditional US whole life uses the carrier’s general account (mostly IG bonds); Meanwhile’s whole life holds bitcoin on the company’s balance sheet, paying the death benefit in BTC. If you’re wondering whether a US shopper can buy in, note the product targeting: BTC Life 1-Pay is specifically structured for non-US taxpayers. The BTC 10-Pay line for US taxpayers is the one an American would evaluate. As with any novel asset-denomination product, the guarantee is the same in form — a fixed death benefit — but the funding currency is volatile, and solvency behavior behaves differently under a crypto balance sheet than under a bond-heavy one. We covered the US-registered, USD-denominated IUL index route to bitcoin exposure via Equitable and Ibexis earlier this year; that’s an index strategy, not a bitcoin-denominated policy, and the two structures aren’t comparable — one pays a USD death benefit with crypto-linked cash-value performance, the other is a crypto balance-sheet policy. For most readers, the takeaway is pattern-level: whole-life product design is being rebuilt around alternative denominations faster than regulation has caught up anywhere.
India’s Big September: Double-Digit First-Year Premium Growth and a Regulator’s Distribution Revamp Call
New data from India’s life insurers provides a window into how one of the world’s largest insurance economies is growing — and what that means for the global reinsurance market that sits behind US carrier pricing. Industry-wide first-year premiums rose 20.6% year-on-year to Rs 48,781 crore in September 2026. Life Insurance Corporation (LIC) posted +19.3% to Rs 27,529 crore; among private carriers, ICICI Prudential Life +25% to Rs 2,701 crore, HDFC Life +18.3% to Rs 4,000 crore, SBI Life +10.4% to Rs 4,035 crore, and GoDigit Life +28.9% to Rs 127 crore. (Source: NDTV Profit, October 8, 2026.)
Rarely noted in English-language coverage: IRDAI member Swaminathan Iyer, speaking to NDTV Profit the same week, said he intends to “revamp the insurance distribution system” — citing fragile customer trust, rising distribution costs, and persistent mis-selling concerns. He’s drawing directly on IRDAI’s own September 23 consultation paper on recalibrating the economics of insurance distribution, which proposed ceding commission caps for life insurers at 15% and 12.5% and a dark-pattern mis-selling clawback. American readers should watch this: India’s formula — “distribution costs too high relative to deliverable value; clawback for mis-sold policies” — is the same argument US state regulators are only starting to put teeth into. The global convergence is real: the world’s two largest life-insurance markets are both rebuilding distribution regulation in the same 12-month window, on similar arguments about cost and fairness, and what regulators in both countries settle on will show up in US illustration requirements and suitability enforcement within 24 months.
Separate but related: ICICI Life announced an MD/CEO transition (Sidharatha Mishra, effective October 14, subject to IRDAI approval, after Anup Bagchi’s resignation), and shareholders approved the carrier’s name change to “ICICI Life Insurance Limited” via a 99.9994% postal-ballot vote on September 19, 2026. For US readers: a name change does not change the policy contract — the regulatory approvals and the carrier’s licensing stay with the legal entity. This is related to our earlier summary of ICICI Prudential’s name change context in our October 8 morning roundup.
Compare Free Life Insurance Quotes
Answer a few questions and see personalized rates from 50+ carriers in about two minutes. No obligation.
Secure form — your information is encrypted and never sold.
Corebridge Insider Flow: Nippon Life Keeps Buying, Revealing Its Long-Term View
Nippon Life, Corebridge Financial’s 10% owner, kept buying Corebridge (NYSE: CRBG) shares through early October via SEC Form 4 disclosures: 272,208 shares on October 1 at $33.07 ($9.0M total), 187,155 shares on October 2 at $34.27 ($6.4M), and 65,711 shares on October 5 at $34.75 ($2.3M). Across the disclosed buy program since September 18, Nippon Life has accumulated more than 3.1 million shares, bringing direct ownership to roughly 126.7 million shares — around $4.4 billion at October’s ~$34.75 price. (Source: SEC Form 4 filings, October 1–5, 2026, as reported by MarketBeat and Defense World.)
There are two ways to read an insurer’s repeated purchases of a US carrier. One: Nippon Life expects Corebridge’s operating profile to resolve favorably, treating the current valuation as attractive for the long run. Two: it’s a staged accumulation executed through a pre-committed buy program rather than a one-off conviction trade. Both can be true at once. For a policyholder, the signal to watch is not the stock — it’s whether a foreign parent’s financial footing changes Corebridge’s affiliate-investment posture or guarantee offerings over time. The best life insurance companies ranking we maintain uses AM Best ratings rather than stock prices for this reason: shareholder flow is an opinion; a carrier rating is a solvency read.
Breaking Down the Rest of October’s Consumer-Protection Calendar
Alongside the lead stories, three additional items deserve a slot in your inbox-checking calendar for October:
- Cash-flow mapping to class-action deadlines: Everyone playing the settlement game maps insurance against deadlines — Anthem’s ERISA proton-beam-therapy denial settlement requires claims by October 10, 2026 (about 140 plan members); the large Globe Life/American Income Life data-breach settlement (532,578 people affected by the October 2, 2024 vendor breach) has a claim deadline of October 19, 2026, offering up to $5,000 in documented losses plus two years of credit monitoring; the Lloyd’s of London syndicate settlement (policies bought Jan 1, 1997–April 15, 2025 through syndicates 727, 1003, 2003, 2020, and 2791) has an October 30, 2026 deadline. If you’re on an affected list, use official settlement sites only — no claim fees are ever charged.
- Government-side settlement payments: the Transamerica COI/monthly-deduction $57 million settlement from 2026 continues processing payments automatically with no claim form (the company admitted no wrongdoing; payments are net of fees). If you hold a Transamerica universal life policy purchased between November 2011 and mid-2024, check your mail and the official administration site rather than waiting for an opt-in card.
- The annuity-rider-fee case is moving: the California teachers vs. Life Insurance Company of the Southwest case over annuity rider fees was stayed after July 15, 2026 class certification, with a formal settlement and preliminary-approval motion expected by October 2, 2026. If it lands, expect a large claims-administration process and a monthly-deduction refund for affected annuity holders.
One promise-in-action note: the NAIC Life Insurance Policy Locator continues to be the single best free tool for finding unclaimed life-insurance benefits — regulators say it has matched $16.99 billion cumulative through July 31, 2026, across 780,000+ matches. (Source: NAIC.) If you’ve ever been a beneficiary of record on a policy you’re unsure about, the locator is free and takes ~15 minutes. Read our full guide to the locator and what to do after a match.
How October’s Stories Fit Together: What This All Means for Your Premium
Reading the week’s cluster together, one pattern keeps repeating: the machinery behind a policy is becoming harder to see. A carrier files its annual statement with an affiliate-investment number of 3–4%; the real number, once federal investigators re-examined it, turns out to be 10x higher. A new bitcoin-native product launches without the consumer-protection bench-strength of a 100-year-old legacy carrier. A Bangladesh regulator, a Korean regulator, and an India regulator all recalibrate distribution rules in different ways over the same three-month window. The buyers most affected won’t be the ones who followed the press release — they’ll be the ones who compared term vs. whole life, checked their carrier’s AM Best rating, and confirmed which of the 2026 crop of carriers they actually placed money with.
The counter-pattern is equally real: term life is getting incrementally cheaper. Both Banner and North American cut rates in this window — which means if your census of term options is more than a year or two old, you’re probably paying a stale premium. The “insurance-market volatility” story is about disclosure-shock, not about term-mortality math changing. A healthy non-smoker buying new 20-year term coverage at $250,000–$750,000 face rarely sees a premium increase year-over-year; the price drift matters if you own permanent coverage, use third-party structure products, or rely on guarantees in a structured policy from a non-legacy carrier.
One staleness trap checked as part of this run: a widely syndicated interview with Meiji Yasuda’s deputy president about Japanese policy surrenders (¥6 trillion+ paid out industry-wide, +40% YoY) surfaced repeatedly in this week’s web searches — but the underlying event date is August 10, 2026, not October. Japan’s surrender surge is real context for the higher-rate environment, and it’s the mirror image of the US story above: rising rates make old policies there look bad against bank deposits, while in America they make new term policies cheaper to quote. We left it in as background rather than headline news for the same reason we left a May 2026-dated 23andMe genetic-data story out: verify the event date, not the article’s publish date.
What to Do Next: A Five-Step Consumer-Facing Checklist for October
- Cross-check your carrier’s AM Best rating directly on AM Best’s site — ratings.ambest.com/search — and note whether the outlook is stable.
- Check the filing deadline schedule for any settlement you might be part of (Anthem, Globe Life/AIL, Lloyd’s all have October deadlines — see the section above).
- If you hold an annuity from a carrier owned by an asset manager, request written documentation of total (not net) related-party exposure, then compare against your carrier’s AM Best capital-adequacy rating.
- If you have a Banner OPTerm or North American ADDvantage application in flight, confirm with your agent whether it preserved pre-change treatment and ask for written confirmation of the rate that will apply.
- If you’ve taken any DTC genetic test (23andMe, Ancestry, etc.), read our underwriting family-history guide before your next application or policy change — as Australia proved this week, what’s banned there is still fully in scope for US life-insurance underwriting.
Frequently Asked Questions About the October 2026 Life Insurance News Cycle
What did the Delaware Life and Clear Spring lawsuit actually allege?
That the carriers reported 3–4% of invested assets in related-party transactions on annual statements, when the restated figures were 42% at Delaware ($18.3B) and 59% at Clear Spring ($5.9B) at year-end 2025, for a combined ~$21 billion in loans to Guggenheim-affiliated entities. The plaintiffs allege this under-reporting constitutes federal wire fraud and deprived elderly annuity buyers of knowledge of the true solvency risk. Both carriers remain rated and operating; the suit is pending, not decided.
Is my annuity safe if my carrier was mentioned in the lawsuit?
Being named in a pending lawsuit is not a solvency event. Policies stay in force, and both carriers continue to pay claims. The actual risk hinges on your carrier’s current AM Best rating and your state’s guaranty-association coverage ($300,000 death benefit / $100,000 cash value in most states). If the carrier’s rating is downgraded or placed under review, that’s the signal to get a second opinion, not the lawsuit itself.
Does the Australian genetic-testing ban apply in the United States?
No. It applies to Australian life-insurance policies only. US life-insurance underwriting remains free to consider genetic data because GINA explicitly excludes life, disability, and long-term-care insurance. California’s AB 1798 (effective January 1, 2027) and Connecticut’s Public Act 26-64 (effective October 1, 2026) create state-level protections but leave the rest of the country without a federal equivalent.
Can I still apply for Banner Life OPTerm at the old rates?
Yes — but only if your formal application (not just a drop ticket) reaches the Banner home office by October 22, 2026. Standing there is a specific rate; the carrier has asked direct-access partners to help applicants who want to pursue the old schedule. Applications received October 23 or later use the new rates. New York applicants are governed by William Penn and a separate May 7 rule.
What is “Bitcoin life insurance” and is it available to ordinary US shoppers?
Meanwhile’s policies hold bitcoin on the carrier’s balance sheet and pay death benefits in BTC rather than dollars. The new BTC Life 1-Pay line is specifically structured for non-US taxpayers; Meanwhile’s earlier BTC 10-Pay line is structured for US taxpayers. It’s a high-net-worth product, not a mainstream retail offering, and it’s not a substitute for a traditional USD-denominated policy. If you want exposure rather than denomination, several US carriers (Equitable, Ibexis) offer index strategies linked to Bitcoin through BlackRock’s IBIT — those are USD-denominated policies with crypto-linked index performance, a very different animal.
Why do carrier rate changes depend on application dates instead of policy dates?
Because a life insurance “policy date” only exists once the carrier issues the contract — which requires the formal signed application plus underwriting approval. State-registered carriers must apply a rate schedule consistently across all applicants on the same form, which means the schedule that governs your application is the one in effect when the application is received, not when you agreed to buy. That’s why lock/sign/submit deadlines — like North American’s September 27 and Banner’s October 22 — exist.
What does LIC or ICICI premium growth mean for a US-based buyer?
Indirectly, plenty. India’s life-insurance market is the world’s largest by policy count, and how its carriers allocate to reserves, product design, and distribution costs influences how global reinsurers price risk — which eventually leaks into US term and FIA pricing. For an individual buyer, the direct effect is negligible: your US policy’s pricing is driven by US mortality tables, US interest rates, and US reinsurance markets. The turn worth watching is whether the US adopts the same distribution-cost-visibility argument India and the US’s own state regulators are making — because that eventually shows up as much-lower-cost distribution for consumers.
Related Resources & Reading
- The Complete Life Insurance Buying Guide for 2026 — how to choose between carriers and product types.
- Term Life Insurance Rates by Age (2026) — age-based pricing tables and how to compare.
- Best Life Insurance Companies of 2026 — AM Best-rated carrier rankings.
- Life Insurance Fraud: Scams and Red Flags (2026) — consumer-side protection guide.
- No Medical Exam Life Insurance: The 2026 Complete Guide
- Burial Insurance for Seniors: Rates, Carriers and Fine Print
- External sources: NAIC Consumer Resources · AM Best Rating Directory · American Banker
Get a Free Life Insurance Quote
Worried about your carrier’s private-credit exposure? Shopping for new term coverage before Banner’s October 22 cutoff? Compare free quotes from 50+ top-rated providers using the tool below — no obligation, no phone call required, and an A.M. Best-strength rating next to every quote.
How LifeQuotesWeb works: we compare quotes from 50+ carriers so you can see real prices in one place. We don’t sell your data to a call-center farm. Ratings shown are current AM Best ratings at press time; rates and product terms change frequently and should be confirmed directly with the carrier’s agent or home office before signing anything.